A Phase IIIB Study to Compare the Efficacy and Safety of Concomitant Treatment in Patients With COPD
Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of the concomitant treatment
of formoterol fumarate with tiotropium bromide compared to treatment with tiotropium bromide
alone.